Additionally, combining EF24 with a JNK inhibitor (JNK-IN-8) caused an additional decrease in invasiveness and MMP-9 activity induced by TPA in NPC cells, indicating a potential combination treatment strategy [37]. Here, MMP9 is linked to nasopharyngeal carcinoma.